Gut microbial load mediates the longevity effect of Korean red ginseng in Drosophila melanogaster.
Key claim: Korean red ginseng extends lifespan in fruit flies by lowering overall gut microbial load, which is required for its modulation of the IIS and Sir2 longevity pathways.
Abstract
Korean red ginseng (KRG) has been reported to modulate gut microbiota and extend lifespan. However, whether the gut microbiota contributes to the longevity effect of KRG remains unclear. Here, using axenic flies and fecal microbiota transplantation, we showed that the lifespan-extending effect of KRG depends on the gut microbiota. Further analyses revealed that KRG exerted minimal effects on microbial diversity and composition, but significantly reduced microbial load. Moreover, gnotobiotic and antibiotic treatment experiments revealed that overall microbial load, rather than any individual dominant taxon, is the key mediator of KRG-mediated longevity. Mechanistically, KRG-mediated regulation of the canonical longevity pathways, IIS and Sir2, was dependent on microbial load. Specifically, the effects of KRG on AKT phosphorylation, FOXO nuclear translocation, and the expression of FOXO target genes and Sir2, observed in conventional flies, were abolished in axenic and antibiotic-treated flies. In addition, neither KRG nor antibiotic treatment extended lifespan in chico or Sir2 mutant flies, and KRG conferred no additional benefit in antibiotic-treated mutants. Collectively, these findings demonstrate that KRG extends lifespan by reducing gut microbial load, thereby modulating the IIS and Sir2 pathways, and highlight microbial load as a key mediator of KRG-induced longevity.
Why this matters
Botanical longevity claims usually invoke direct molecular targets; this fly study reframes Korean red ginseng’s lifespan effect as microbiome-mediated, with reduced gut microbial load acting as a necessary upstream condition for IIS and Sir2 modulation. If it generalizes, other ‘nutrient-sensing’ botanicals may be operating partly through microbial burden rather than direct host-pathway pharmacology — but the evidence is Drosophila-only, and the default caveat about model-organism translation applies fully.